CVE-2023-27001

Egerie privilege escalation

8.8 HIGHPublic exploitEPSS 0.95%

Published8 Feb 2024

Description

An issue discovered in Egerie Risk Manager v4.0.5 allows attackers to bypass the signature mechanism and tamper with the values inside the JWT payload resulting in privilege escalation.

CVSS 3.1 breakdown

Attack vectorNetwork

Attack complexityLow

Privileges requiredLow

User interactionNone

ScopeUnchanged

ConfidentialityHigh

IntegrityHigh

AvailabilityHigh

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Affected products

Egerie4.0.5

Remediation

No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.

References

https://github.com/post-cyberlabs/CVE-Advisory/blob/main/CVE-2023-27001.pdfExploitThird Party Advisory

Frequently asked

Is CVE-2023-27001 being actively exploited?

CVE-2023-27001 is not in the CISA KEV catalog. A public exploit reference exists, so treat it as exploitable. Its EPSS exploit probability is 0.95%.

How severe is CVE-2023-27001?

CVE-2023-27001 has a CVSS 3.1 base score of 8.8, rated high. EPSS estimates a 0.95% probability of exploitation.

Which products are affected by CVE-2023-27001?

Affected products include Egerie.

How do I fix CVE-2023-27001?

Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2023-27001 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

See how prioritisation works Book a demo

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.